COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,302 Articles (22,772 medRxiv, 8,530 bioRxiv)

Most recent first Previous |  Page 1016: Articles 10151-10160  | Next

An integrated lab-on-a-chip device for RNA extraction, amplification and CRISPR-Cas12a-assisted detection for COVID-19 screening in resource-limited settings
Ngamsom, B., Iles, A., Kamita, M., Kimani, R., Rodriguez-Mateos, P., Mungai, M., Dyer, C. E., Walter, C., Gitaka, J., Pamme, N.
10.1101/2022.01.06.22268835 — Posted: 2022-01-06 Discussion: Offsite
The impact of vaccination on incidence and outcomes of SARS-CoV-2 infection in patients with kidney failure in Scotland
Bell, S., Campbell, J., Lambourg, E., Watters, C., O'Neill, M., Almond, A., Buck, K., Carr, E., Clark, L., Cousland, Z., Findlay, M., Joss, N., Metcalfe, W., Petrie, M., Spalding, E., Traynor, J., Sanu, V., Thomson, P., Methven, S., Mark, P.
10.1101/2022.01.05.22268785 — Posted: 2022-01-06
Diminished antibody response against SARS-CoV-2 Omicron variant after third dose of mRNA vaccine in kidney transplant recipients
Al Jurdi, A., Benedetti Gassen, R., De Jesus Borges, T., Tadeval Lape, I., Morena, L., Efe, O., Solhjou, Z., El Fekih, R., Deban, C., Bohan, B., Pattanayak, V., Kotton, C., Azzi, J., Riella, L. V.
10.1101/2022.01.03.22268649 — Posted: 2022-01-06
Mental health assessment of Israeli adolescents before and during the COVID-19 pandemic
Bilu, Y., Flaks-Manov, N., Bivas-Benita, M., Akiva, P., Kalkstein, N., Yehezkelli, Y., Mizrahi-Reuveni, M., Aka-Zohar, A., Shapiro Ben David, S., Lerner, U., Bodenheimer, G., Greenfeld, S.
10.1101/2022.01.06.22268809 — Posted: 2022-01-06 Discussion: Onsite
Adherence of SARS-CoV-2 delta variant to surgical mask and N95 respirators
Lorenzo-Leal, A. C., Vimalanathan, S., Bach, H.
10.1101/2022.01.05.22268808 — Posted: 2022-01-06
The Governance of Pandemics in Primary Health Care: The Governance Strategies Adopted by Health Facility Governing Committees in Times of COVID Pandemic in Tanzania
Kesale, A. M., Mahonge, C., Muhanga, M.
10.1101/2022.01.03.22268663 — Posted: 2022-01-06
Durability of Protection against COVID-19 Breakthrough Infections and Severe Disease by Vaccines in the United States
Zheutlin, A., Ott, M., Sun, R., Zemlianskaia, N. Z., Rubel, M., Hayden, J., Neri, B., Kamath, T., Khan, N., Schneeweiss, S., Sarsour, K.
10.1101/2022.01.05.22268648 — Posted: 2022-01-06
Association between vaccination status and reported incidence of post-acute COVID-19 symptoms in Israel: a cross-sectional study of patients infected between March 2020 and November 2021
Kuodi, P., Gorelik, Y., Zayyad, H., Wertheim, O., Beiruti Wiegler, K., Abu Jabal, K., Dror, A., Nazzal, S., Glikman, D., Edelstein, M.
10.1101/2022.01.05.22268800 — Posted: 2022-01-06 Discussion: Onsite
The impact of demographic factors on numbers of COVID-19 cases and deaths in Europe and the regions of Ukraine
Nesteruk, I., Rodionov, O.
10.1101/2022.01.05.22268787 — Posted: 2022-01-06
Vaccinating children against COVID-19: commentary and mathematical modelling
Hawkes, M. T., Good, M. F.
10.1101/2022.01.05.22268820 — Posted: 2022-01-06

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).